BioMaxima, one of the fastest growing life science companies in Europe, according to Financial Times/Statista
Biomaxima SA was listed in the prestigious FT 1000: Europe's Fastest Growing Companies ranking, listing 1000
companies from all over Europe that achieved the highest compound annual growth rate in revenue between 2018
and 2021. BioMaxima SA was included in the ranking in the "Health Care & Life Sciences" category for the first time.
“We are very pleased that the dynamic growth of BioMaxima has been noticed and that the company was listed by
the Financial Times in this prestigious ranking. Such rapid growth was possible thanks to the reinvestment of the
funds earned by the company, as well as because of the systematic hard work of our team. We are consistently
implementing the strategy of building a strong Polish manufacturer of tests for infectious disease diagnostics, the
only manufacturer of antibiotic susceptibility testing (AST) systems in Central Europe. Following this momentum, in
the coming months, we will launch a new production facility which will take BioMaxima to the next level of
development.” - said Łukasz Urban, CEO of the board of BioMaxima SA.
The new BioMaxima production plant will accommodate the production of antibiotic susceptibility testing systems
(AST), extra production capacity for rapid immunochromatographic tests, supplements for microbiology media, and
reagents for molecular diagnostics. An important element of capacity expansion encompassed by the new
investment will be a significant expansion of the segment of microbiology media and disc diffusion systems for drug
susceptibility testing on the premises of the existing plant.
BioMaxima S.A. is a Warsaw Stock Exchange listed Polish company operating on the laboratory diagnostics market.
The company specializes in infectious disease diagnostics, including microbiology, antibiotic susceptibility testing
systems (AST), as well as a wide range of reagents and equipment for in vitro diagnostics. The company is also a
distributor of products of recognized global diagnostic companies. BioMaxima SA supplies with its products over
2,000 customers in Poland and in over 60 international markets